ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
224.46
-2.28 (-1.01%)
Aug 14, 2026, 4:00 PM EDT - Market closed
ResMed Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 32,379 | 28,145 | 37,762 | 28,117 | 32,133 | 30,691 | |
Market Cap Growth | -23.29% | -25.47% | 34.31% | -12.50% | 4.70% | -14.52% |
Enterprise Value | 31,736 | 27,327 | 37,669 | 29,025 | 33,617 | 31,303 |
Last Close Price | 224.46 | 194.88 | 255.50 | 187.87 | 212.20 | 202.00 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 21.52 | 18.48 | 26.96 | 27.54 | 35.80 | 39.38 |
Forward PE | 18.56 | 16.42 | 25.32 | 22.86 | 30.82 | 34.10 |
PS Ratio | 5.73 | 4.98 | 7.34 | 6.00 | 7.61 | 8.58 |
PB Ratio | 4.92 | 4.27 | 6.33 | 5.78 | 7.78 | 9.13 |
P/TBV Ratio | 10.05 | 8.73 | 15.37 | 18.30 | 39.81 | 28.46 |
P/FCF Ratio | 19.63 | 17.06 | 22.73 | 21.60 | 56.02 | 141.88 |
P/OCF Ratio | 17.93 | 15.59 | 21.56 | 20.07 | 46.35 | 87.40 |
PEG Ratio | 1.40 | 1.16 | 1.65 | 1.54 | 2.39 | 2.45 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 5.61 | 4.83 | 7.32 | 6.20 | 7.96 | 8.75 |
EV/EBITDA Ratio | 15.14 | 12.88 | 20.25 | 18.93 | 26.02 | 27.80 |
EV/EBIT Ratio | 16.53 | 14.23 | 22.32 | 20.97 | 29.18 | 31.24 |
EV/FCF Ratio | 19.24 | 16.57 | 22.67 | 22.30 | 58.60 | 144.71 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.13 | 0.13 | 0.14 | 0.18 | 0.38 | 0.27 |
Debt / EBITDA Ratio | 0.38 | 0.38 | 0.45 | 0.56 | 1.19 | 0.79 |
Debt / FCF Ratio | 0.50 | 0.50 | 0.51 | 0.67 | 2.75 | 4.24 |
Net Debt / Equity Ratio | -0.10 | -0.10 | -0.06 | 0.13 | 0.33 | 0.19 |
Net Debt / EBITDA Ratio | -0.30 | -0.30 | -0.19 | 0.41 | 1.05 | 0.56 |
Net Debt / FCF Ratio | -0.39 | -0.39 | -0.21 | 0.49 | 2.36 | 2.93 |
Asset Turnover | 0.66 | 0.66 | 0.68 | 0.69 | 0.71 | 0.73 |
Inventory Turnover | 2.26 | 2.26 | 2.09 | 1.87 | 1.84 | 2.30 |
Quick Ratio | 1.80 | 1.80 | 2.16 | 1.22 | 1.23 | 1.28 |
Current Ratio | 3.10 | 3.10 | 3.44 | 2.59 | 3.12 | 2.80 |
Return on Equity (ROE) | 24.27% | 24.27% | 25.86% | 22.70% | 23.96% | 24.96% |
Return on Assets (ROA) | 14.00% | 14.00% | 14.02% | 12.70% | 12.15% | 12.75% |
Return on Invested Capital (ROIC) | 26.23% | 26.38% | 25.36% | 20.35% | 19.81% | 22.04% |
Return on Capital Employed (ROCE) | 25.40% | 25.40% | 23.60% | 23.20% | 19.20% | 22.70% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 4.70% | 5.41% | 3.71% | 3.63% | 2.79% | 2.54% |
FCF Yield | 5.09% | 5.86% | 4.40% | 4.63% | 1.79% | 0.70% |
Dividend Yield | 1.18% | 1.23% | 0.83% | 1.02% | 0.83% | 0.83% |
Payout Ratio | 25.31% | 22.95% | 22.19% | 27.65% | 28.78% | 31.48% |
Buyback Yield / Dilution | 0.87% | 0.87% | 0.14% | -0.06% | -0.28% | -0.40% |
Total Shareholder Return | 2.05% | 2.10% | 0.97% | 0.96% | 0.55% | 0.43% |